FIELD: chemistry.
SUBSTANCE: invention describes a method of determining whether a compound is a neurotrypsin inhibitor, as well as a method of measuring catalytic activity of neurotrypsin, where the tested compound is incubated together with human or mouse neurotrypsin or a fragment of human or mouse neurotrypsin which contains a neurotrypsin protease domain, and with a complete length or soluble agrin, or agrin-C45, or a fluorescent protein, or a peptide containing agrin, agrin-C45, in an aqueous buffer solution at pH 7.5 and the number of agrin cleavages is measured.
EFFECT: improved properties.
| Title | Year | Author | Number |
|---|---|---|---|
| INVENTION OF PROTEIN PI4KIIIA AND RELATED MEMBRANE PROTEIN COMPLEX IN TREATMENT OF ALZHEIMER'S DISEASE | 2016 |
|
RU2724493C2 |
| PEPTIDES AND THEIR DERIVATIVES WHICH INTERACT WITH NICOTINIC ACETYLCHOLINE RECEPTOR AND SUITABLE FOR USE IN COSMETOLOGY AGAINST MIMIC AND AGE-RELATED WRINKLES | 2013 |
|
RU2524428C1 |
| ESCHERICHIA coli BL21(DE3)/ pET32 v 11-Cre CELL STRAIN PRODUCING SITE-SPECIFIC Cre RECOMBINASE | 2020 |
|
RU2761637C1 |
| USING TPK AS A TARGET IN ALZHEIMER'S DISEASE | 2020 |
|
RU2804334C2 |
| AGENTS, APPLICATION WAYS AND METHODS FOR TREATING SYNUCLEOPATHY | 2016 |
|
RU2765303C2 |
| GENETIC NUCLEOTIDE SEQUENCES OF ARTIFICIALLY MODIFIED GDNF WITH DELETED pro-REGION, PRODUCT OF WHICH HAS IMPROVED PROPERTIES NEURAL INDUCTOR AND STIMULATOR OF FORMATION OF NEURAL PROCESSES, SUITABLE FOR THERAPY OF NEURAL INJURIES, ISCHEMIC STROKES AND NEURODEGENERATIVE DISEASES, EXPRESSION VECTOR, MODIFIED WITH GDNF | 2014 |
|
RU2595377C2 |
| GENE TRANSITION MEDIATED BY LENTIVIRAL VECTOR AND METHOD FOR USING THE GENES | 2001 |
|
RU2288742C2 |
| TRANSGENIC ANIMAL THAT DIFFERS FROM HUMAN, AND ITS APPLICATION | 2010 |
|
RU2579701C2 |
| COMPOSITIONS AND METHODS FOR TOXIGENIC TESTING | 2012 |
|
RU2616281C2 |
| MODIFIED BIOSENSOR FOR DETECTING INTRACELLULAR PH | 2014 |
|
RU2603060C2 |
